FibroBiologics, Inc. Common Stock (FBLG)
Healthcare
Biotechnology
0.79 $
+12.9%
vs. previous close
Closing price · As of: 3. Aug 2026
FibroBiologics, Inc. Common Stock (FBLG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| -1.2 | -1.4 | -4.1 | -6.4 | -12 | -16 | |
| – | 0.0 | 0.1 | 0.4 | 0.6 | 0.8 | |
| – | 0.0 | 0.3 | 1.8 | 2.2 | 2.7 | |
| – | 0.2 | 0.3 | 0.5 | 0.6 | -3.3 | |
| 0.0 | 0.0 | 0.0 | 0.5 | 0.2 | 0.3 | |
| – | – | – | -0.5 | -0.2 | -0.3 | |
| – | 1.5 | 3.8 | 0.3 | 9.4 | 1.0 | |
| 1.2 | 1.8 | 5.9 | 14 | 17 | 7.6 | |
| – | 0.4 | 1.9 | 6.9 | 4.8 | -9.1 | |
| -1.2 | -1.4 | -4.1 | -6.9 | -12 | -17 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.